Table 3 Clinical characteristics of AML patients
Characteristic | Newly diagnosed (n = 28) | Relapsed/refractory (n = 13) | Complete remission (n = 19) |
|---|---|---|---|
Age, y | |||
 Median | 52 | 53 | 42 |
 Range | 13–78 | 18–69 | 18–68 |
Male, n (%) | 16 (28) | 7 (13) | 11 (19) |
WBC, ×  109/L | |||
 Median | 7.14 | 2.73 | 4.64 |
 Range | 1.2–263.1 | 1.2–198.4 | 1.05–21.56 |
HGB, g/L | |||
 Median | 79 | 79 | 118 |
 Range | 3–135 | 32–109 | 66–144 |
PLT, × 109/L | |||
 Median | 39 | 47 | 174 |
 Range | 5–569 | 8–357 | 128–338 |
Blast in bone marrow, % | |||
 Median | 77.56 | 44 | 1.57 |
 Range | 13.63–97.00 | 10–91 | 0.36–3.15 |
FAB classification | |||
 M0 | 0 | 0 | 1 |
 M1 | 2 | 1 | 0 |
 M2 | 3 | 2 | 2 |
 M3 | 0 | 0 | 3 |
 M4 | 1 | 0 | 3 |
 M5 | 14 | 9 | 10 |
 M6 | 0 | 0 | 0 |
 M7 | 0 | 0 | 0 |
 Unclassified | 8 | 1 | 0 |
Cytogenetics, n (%) | |||
 Normal | 11 | 6 | 15 |
 Abnormal | 13 | 6 | 2 |
 Unknown | 4 | 1 | 2 |